Top Markets
Coin of the day
Entia Biosciences, Inc. Entia Biosciences, Inc.

Entia Biosciences, Inc.

ERGO
Rangering i aksjer #41967
Entia Biosciences, Inc. engages in the development, production, and... Entia Biosciences, Inc. engages in the development, production, and distribution of dietary supplements, nutraceuticals, and medical food products in the United States. The company develops ErgoD2, a pharmaceutical grade organic compound for the improvement of iron homeostasis and mitigation of iron-related disorders presenting in anemia, chronic kidney disease, and select neurodegenerative diseases. It is also involved in the discovery, scientific evaluation, and marketing of natural formulations that can be used in medical food, nutraceuticals, cosmetics, and other products. In addition, the company offers beauty products under the GROH brand name. It markets its products directly to consumers through e-commerce channels, such as direct email marketing, social media outlets, and e-commerce sites. The company was formerly known as Total Nutraceutical Solutions, Inc. and changed its name to Entia Biosciences, Inc. in January 2012. Entia Biosciences, Inc. was incorporated in 2007 and is headquartered in Sherwood, Oregon.
Aksjekurs
$0.0002
Sist synkronisert: 2026-08-11
Markedsverdi
$6.73K
Endring (1 dag)
0.00%
Endring (1 år)
100.00%
Land
US
Handel Entia Biosciences, Inc. (ERGO)

Kategori

Inntekter for Entia Biosciences, Inc. (ERGO)
Inntekter i 2026 TTM: 0
Ifølge Entia Biosciences, Inc. sine nyeste økonomiske rapporter er selskapets nåværende resultat 0. I 2026 hadde selskapet et resultat på 0, lik resultatet i 2026, som var 0. Resultatet som vises på denne siden er resultat før renter og skatt, eller EBIT.
Inntektshistorikk for Entia Biosciences, Inc. fra 2026 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
Ikke nok data for de angitte datoene.
Inntekter for lignende selskaper eller konkurrenter